High‑Specificity Point‑of‑Care Micro Biochip for Improved Diagnostic Accuracy (Enhanced Sensitivity and Specificity for Point‑of‑Care (POC) Micro Biochip, Tech ID: 17‑032)
Technology Overview: This technology delivers an enhanced POC micro biochip designed to improve both sensitivity and specificity in diagnostic testing. Through optimized fluidic pathways and assay architecture, the chip minimizes non‑specific binding while maximizing detection of target biomarkers. The platform supports rapid, reliable diagnostics in decentralized settings and is adaptable to multiple disease states and biomolecular targets.
Industry Pain Point: Many POC diagnostics trade accuracy for speed, limiting clinical confidence.
NJIT Solution: This biochip maintains laboratory‑level accuracy while enabling rapid POC testing.
Key Features & Advantages
- Enhanced sensitivity and specificity
- Reduced false positives and negatives
- Rapid test turnaround
- Small, portable form factor
Development Stage: TRL 5–6 – Device validation completed.
Target Markets
- Point‑of‑care diagnostics
- Infectious disease testing
- Decentralized healthcare delivery
Market Opportunity
- Global point‑of‑care diagnostics market (2026): ~$45B
- CAGR: ~9–10%
- Projected market size (2035): ~$95–100B
Commercial & IP Details
Inventors: Eon Soo Lee, Bharath Babu Nunna